One Brexit-proof stock that I’d buy today

Read this to find out why I think this AIM stock could deliver impressive returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Public domain.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

There are not many sectors which I would consider to have an almost guaranteed long-term upside, but the one that stands out is healthcare. The world has an ageing population, therefore the potential growth of this sector could be unlimited.

One company that services this market is Craneware (LSE:CRW), a Scottish firm that sells billing software to the US healthcare industry to deliver savings for its clients. Its focus is on the largest and most competitive market in the world, which is a shrewd move as success in America gives it the best chance to carve an impressive international market share for its product. Its software is currently used by around a quarter of US hospitals so it has plenty of room to grow, and as my Foolish colleague Roland Head points out, once the products are used by hospitals it is very difficult to replace them. This helps growth as existing revenues are well protected.

Is the company overpriced?

It fits the profile that I look for in a stock, with very good return on capital employed (ROCE) of 36% and a good operating margin at 28%. These attributes make it a high quality stock and such companies normally trade at a premium. Craneware is no exception as the price-to-earnings ratio (P/E), stands at a hefty 42x. This still seems a bit rich considering a growth rate of around 15%, but is there another reason for the premium? Software companies can scale very quickly and I think a lot of market participants feel there could be a bumper set of half-year results on the way on March 5.

The trigger for the big re-rating in the share was the earlier full-year results (although it has now been dragged back by market conditions). These were good, but I think the main cause for excitement among investors was the news of a 100% increase in new sales, considering the company has an excellent retention rate, this could make for a very good year. The firm is also releasing a new product, Trisus, which it says has had positive results from early adopters. 

Backed by management

I like founder-run companies, especially where they have a lot of skin in the game, and on September 10, following the FY results, the CEO purchased £150k of stock to take his holding to 12.7%. This is a big show of confidence considering that the P/E ratio at the time was around 50, a level at which you may expect an insider to consider taking some profits.

Brexit-proof?

While I personally feel that Brexit problems should be resolved long term, one of the benefits of this business is that most of its revenues come from the US, therefore the company will benefit from any falls in the pound against the dollar. Nevertheless the share price has fallen recently showing how temperamental the stock market can be in uncertain times.

With this in mind I might wait for a bit more certainty in the markets before I think about buying Craneware, but this is an exciting stock that I’d be happy to own. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Robert Faulkner owns no position in any of the shares mentioned. The Motley Fool UK has recommended Craneware. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »